Aspira Women's Health Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-07. Between them they name 3 people, with 2 appointments and 2 departures. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Michael Buhle, Chief Executive Officer, effective 2026-06-17
This Amendment No. 1 to Current Report on Form 8-K (this "Amendment") amends the Current Report on Form 8-K filed by Aspira Women's Health Inc. (the "Company") with the Securities and Exchange Commission on June 22, 2026 (the "Original Report"), which reported, among other things, that Michael Buhle ceased serving as the Company's Chief Executive Officer effective June 17, 2026 (the "Separation Date") and that the Board of Directors (the "Board") appointed John (Jack) Fraser as Interim Chief Executive Officer.
Departing: Michael Buhle, Chief Executive Officer
On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").
Appointed: John Fraser, Chief Executive Officer, effective 2026-06-17
Effective June 17, 2026, the board of directors (the "Board") of the Company appointed John Fraser, the Company's current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.
Appointed: John Strahley, Chief Financial Officer and Chief Accounting Officer, effective 2026-04-27
On April 26, 2026, Aspira Women's Health, Inc. (the "Company") appointed John Strahley as Chief Financial Officer and Chief Accounting Officer of the Company, effective April 27, 2026.
Aspira Women's Health Inc.'s funding history
Find people with the same kind of experience as the Chief Executive Officer at Aspira Women's Health Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Aspira Women's Health Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Aspira Women's Health Inc. is in the news or changes leadership.
Get an alert when Aspira Women's Health Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Aspira Women's Health Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.